Anticoagulant choices in pregnant women with mechanical heart valves: Balancing maternal and fetal risks – the difference the dose makes
- 1 January 2013
- journal article
- conference paper
- Published by Elsevier in Thrombosis Research
- Vol. 131, S8-S10
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Anticoagulation during pregnancy in patients with a prosthetic heart valveNature Reviews Cardiology, 2012
- An audit of pregnant women with prosthetic heart valves at a tertiary hospital in South AfricaCardioVascular Journal of Africa, 2012
- Mechanical valve prosthesis and anticoagulation regimens in pregnancy: a tertiary centre experienceEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
- ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)European Heart Journal, 2011
- The effect of warfarin dosage on maternal and fetal outcomes in pregnant women with prosthetic heart valvesObstetric Medicine, 2011
- Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy optionThrombosis Research, 2011
- Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparinBJOG: An International Journal of Obstetrics & Gynaecology, 2009
- Risk of warfarin during pregnancy with mechanical valve prosthesesObstetrics & Gynecology, 2002
- Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valvesJACC, 1999
- Maternal and fetal sequelae of anticoagulation during pregnancyThe American Journal of Medicine, 1980